Antimycobacterial activity of lipodepsipeptides produced by Pseudomonas syringae pv syringae B359

  • E. Buber
  • , A. Stindl
  • , N. L. Acan
  • , T. Kocagoz
  • , R. Zocher

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Some lipodepsipeptides produced by Pseudomonas syringae pv. syringae showed strong antimycobacterial activity towards Mycobacterium smegmatis. MIC values found were between 1.5-3.2 μg/ml, which is comparable to some primary drugs for tuberculosis. Among the lipodepsipeptides, Syringomycin E (SRE) appears to be the most potent antimycobacterial agent.

Original languageEnglish
Pages (from-to)419-423
Number of pages5
JournalNatural Product Letters
Volume16
Issue number6
DOIs
Publication statusPublished - Dec 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antimycobacterial activity
  • Lipodepsipeptides
  • Mycobacterium
  • Pseudomonas syringae pv.syringae
  • Syringomycin E
  • Syringopeptin 22a

Fingerprint

Dive into the research topics of 'Antimycobacterial activity of lipodepsipeptides produced by Pseudomonas syringae pv syringae B359'. Together they form a unique fingerprint.

Cite this